iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock?Zacks Investment Research • 10/23/24
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst SaysBenzinga • 10/22/24
iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT DeviceGlobeNewsWire • 10/21/24
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024GlobeNewsWire • 10/16/24
Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the FirmGlobeNewsWire • 09/20/24
iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial IntelligenceGlobeNewsWire • 09/11/24
iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 MeetingGlobeNewsWire • 09/09/24
iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and SpainGlobeNewsWire • 08/29/24
iRhythm Technologies to Participate in Upcoming Investor Conferences in SeptemberGlobeNewsWire • 08/21/24
All You Need to Know About iRhythm Technologies (IRTC) Rating Upgrade to BuyZacks Investment Research • 08/07/24
IRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/01/24
iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024GlobeNewsWire • 07/18/24
This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For ThursdayBenzinga • 06/20/24
iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing AutomationGlobeNewsWire • 06/17/24